Titlebook: Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders; Elisabeth J. Van Bockstaele Book 2013 Springer Science

Euphonious

Endocannabinoids, Monoamines and Stress,ess-adaptation. Similarly, serotonin, norepinephrine, and dopamine are important modulators and effectors of stress. The purpose of this review is to present and discuss the results of studies that have investigated the interactions between endocannabinoid-CB1 receptor signaling and each of the biog

彻底明白

Chronic Effects of Cannabinoid Drugs on Monoaminergic Systems and the Role of Endocannabinoids and a functional coupling with the monoaminergic systems in the brain. Norepinephrine, serotonin (5-HT) and dopamine systems are modulated via inhibitory CB. receptors by direct or indirect effects. The repeated stimulation of CB. receptors (and receptor desensitization) can lead to the induction of to

杠杆支点

Endocannabinoid Signaling and the Regulation of the Serotonin System,y regulate neuronal functions and behaviors by activating cannabinoid receptors. The ubiquitous distribution of eCBs in neuronal populations that are associated with stress responses, such as dorsal raphe nucleus (DRn) serotonin (5-HT) neurons suggests that eCB signaling plays a central role in the

暴行

Modulation of Serotonin Firing Activity Through CB1 Agonists and FAAH Inhibitors,e low mood and depression especially after chronic use. Despite these clinical evidences, little was known about the capacity of cannabis to modulate serotonin (5-Hydroxytryptamine, 5-HT), the main neurotransmitter implicated in the regulation of mood and the pathology of mood disorders..In the past

烦人

抚慰

Armada

Relay Feedback and its Variationse an overview of the endocannabinoid system, a summary of current cannabinoid receptor nomenclature, and pharmacological principles as well as electrophysiological, biochemical, and behavioral evidence for cannabinoid modulation of dopaminergic, noradrenergic, and serotonergic circuitry.

Geyser

irradicable

Book 2013tion of monoaminergic (dopamine, norepinephrine, and serotonin) circuits is becoming more clear.  Scientists have shown significant interaction between these two systems in a variety of psychiatric and neurological disorders such as affective disorders, multiple sclerosis, and pain or pain disorders

恶心

https://doi.org/10.1007/978-981-19-1836-0nia. This review aims at: (1) presenting the complex functional interactions between these two neurotransmitter systems at the anatomical, pharmacological, cellular and electrophysiological levels, and (2) addressing the contribution of disturbances of cannabinoid–dopamine interactions to neurodegenerative and psychiatric disorders.